Press Releases

iSTAR Medical receives U.S. FDA approval to start pivotal trial for MINIject in glaucoma patients

World-leading surgeons to join iSTAR Medical’s STAR-V study WAVRE, Belgium — 15 July 2021: iSTAR Medical, a med-tech company developing minimally-invasive implants for glaucoma surgery (MIGS), announced today that the U.S. Food and Drug Administration (FDA) granted it Investigational Device Exemption (IDE) to start a pivotal trial with MINIjectTM. The STAR-V study will investigate MINIjectTM […]

iSTAR Medical recruits Paul van Hagen as CFO

WAVRE, Belgium — 29 June 2021: iSTAR Medical, a med-tech company developing minimally-invasive implants for glaucoma treatment, announced today that Paul van Hagen has joined the company as Chief Financial Officer (CFO).

iSTAR Medical’s glaucoma device MINIject shows positive one-year results in European trial

Growing body of evidence confirms MINIject is safe and effective with results sustained over time

Positive outcomes for iSTAR Medical’s MIGS MINIject shown in trials of over 130 glaucoma patients

Pooled data confirm excellent safety and efficacy profile with very low rate of reintervention

First truly biocompatible MIGS implant from iSTAR Medical shows consistently outstanding efficacy in patients with glaucoma

Two-year final results from STAR-I trial and initial data from STAR-II European trial tout MINIjectTM as a highly promising treatment.